Bilateral inferior petrosal sinus sampling.

Cushing's syndrome is a complex condition marked by excessive cortisol production. While clinical and imaging methods help identify hypercortisolism, they often fail to distinguish its source. Prior research has shown that biochemical tests alone lack precision in determining whether the pituitary or an ectopic site is the cause. This gap motivated the development of more targeted diagnostic tools. Simultaneous bilateral inferior petrosal sinus sampling has emerged as a promising technique. It allows for direct measurement of ACTH levels in the pituitary venous drainage. The procedure is particularly useful in confirming pituitary ACTH excess. However, no prior work had resolved the limitations of using interpetrosal ACTH gradients alone for tumor localization. The need for a more accurate diagnostic method remains a key challenge in endocrinology.

The study aimed to evaluate the role of simultaneous bilateral inferior petrosal sinus sampling in diagnosing Cushing's syndrome. It focused on the procedure's accuracy in differentiating pituitary from ectopic sources of ACTH. The researchers sought to clarify the diagnostic value of this technique compared to other methods. They also examined the impact of corticotrophin-releasing hormone stimulation on test sensitivity. The motivation for this study stemmed from the limitations of non-invasive diagnostic approaches. The goal was to establish the conditions under which BIPSS should be performed. The study emphasized the importance of performing the test during hypercortisolemia. The researchers aimed to highlight the risks and benefits of this invasive procedure.

The study reviewed the diagnostic utility of simultaneous bilateral inferior petrosal sinus sampling. It analyzed the sensitivity and specificity of the procedure in identifying pituitary ACTH excess. The researchers compared BIPSS results with those from clinical, biochemical, and imaging assessments. They evaluated the effect of corticotrophin-releasing hormone on ACTH secretion. The study also considered the timing of the procedure in relation to hypercortisolemia. The accuracy of interpetrosal ACTH gradients for tumor localization was assessed. The researchers examined the role of experienced operators in minimizing adverse events. The study included a review of published data on BIPSS outcomes and complications.

The study found that BIPSS has a sensitivity of 88-100% and a specificity of 67-100% in diagnosing pituitary ACTH excess. ACTH levels in the inferior petrosal sinuses were consistently higher than in peripheral blood. Corticotrophin-releasing hormone stimulation improved the procedure's sensitivity. The procedure must be performed during hypercortisolemia to suppress normal corticotroph activity. Tumor-derived ACTH is the primary source of elevated sinus levels. The positive predictive value for tumor lateralization was 50-70%. Interpetrosal ACTH gradients alone are insufficient for tumor localization. The study confirmed that adverse events are rare when performed by experienced operators.

The authors concluded that BIPSS is the most accurate method for differentiating pituitary from ectopic ACTH sources. The procedure should be performed during hypercortisolemia to ensure accurate results. Corticotrophin-releasing hormone enhances the sensitivity of the test. Interpetrosal ACTH gradients have limited value for tumor localization. An accurate gland exploration is recommended if no tumor is found in the predicted area. The procedure is considered safe when performed by experienced operators. The study emphasized the importance of referral centers for BIPSS. The authors proposed that BIPSS remains a crucial diagnostic tool in Cushing's syndrome.